Literature DB >> 15820341

Prevalence of and risk factors for anxiety and depressive disorders in Nigerian adolescents with epilepsy.

Abiodun O Adewuya1, Bola A Ola.   

Abstract

The emotional response of adolescents to a chronic illness like epilepsy may differ across cultures. This study was aimed at investigating the prevalence of and risk factors for anxiety and depressive disorders in a group of Nigerian adolescents with epilepsy. Adolescents with epilepsy (n=102) aged between 12 and 18 were assessed for anxiety and depressive disorders with the Diagnostic Interview Schedule for Children Version IV (DISC-IV). An anxiety disorder was diagnosed in 32 (31.37%) of the adolescents and a depressive disorder was reported in 29 (28.43%). Predictors of anxiety and depressive disorders by regression analysis include uncontrolled seizures, polytherapy, and felt stigma. Family factors such as parents' psychopathology and family stress are also moderately significant. Results show that emotional disorders in adolescents with epilepsy cut across cultures. Adequate monitoring, education targeted at reducing felt stigma, and family intervention programs are needed for early intervention.

Entities:  

Mesh:

Year:  2005        PMID: 15820341     DOI: 10.1016/j.yebeh.2004.12.011

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  21 in total

1.  Examining clinically relevant levels of depressive symptoms in mothers following a diagnosis of epilepsy in their children: a prospective analysis.

Authors:  Mark Anthony Ferro; Kathy Nixon Speechley
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-11-09       Impact factor: 4.328

Review 2.  Anxiety and epilepsy: what neurologists and epileptologists should know.

Authors:  Heidi M Munger Clary
Journal:  Curr Neurol Neurosci Rep       Date:  2014-05       Impact factor: 5.081

3.  Depression and anxiety in children with epilepsy and other chronic health conditions: National estimates of prevalence and risk factors.

Authors:  Brian LaGrant; Belinda Oyinkan Marquis; Anne T Berg; Zachary M Grinspan
Journal:  Epilepsy Behav       Date:  2019-12-20       Impact factor: 2.937

4.  Children with epilepsy and anxiety: Subcortical and cortical differences.

Authors:  Jana E Jones; Daren C Jackson; Karlee L Chambers; Kevin Dabbs; David A Hsu; Carl E Stafstrom; Michael Seidenberg; Bruce P Hermann
Journal:  Epilepsia       Date:  2015-01-12       Impact factor: 5.864

5.  A model for internalized stigma in children and adolescents with epilepsy.

Authors:  Joan K Austin; Susan M Perkins; David W Dunn
Journal:  Epilepsy Behav       Date:  2014-05-24       Impact factor: 2.937

6.  Validation of the Health-Related Felt Stigma and Concealment Questionnaire.

Authors:  Kelsey T Laird; Craig A Smith; Steven D Hollon; Lynn S Walker
Journal:  J Pediatr Psychol       Date:  2020-06-01

7.  Behavioural comorbidity in Tanzanian children with epilepsy: a community-based case-control study.

Authors:  Kathryn Burton; Jane Rogathe; Ewan Hunter; Matthew Burton; Mark Swai; Jim Todd; Brian Neville; Richard Walker; Charles Newton
Journal:  Dev Med Child Neurol       Date:  2011-12       Impact factor: 5.449

Review 8.  Variation of the prevalence of pediatric polypharmacy: A scoping review.

Authors:  Courtney Baker; James A Feinstein; Xuan Ma; Shari Bolen; Neal V Dawson; Negar Golchin; Alexis Horace; Lawrence C Kleinman; Sharon B Meropol; Elia M Pestana Knight; Almut G Winterstein; Paul M Bakaki
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-02-06       Impact factor: 2.890

Review 9.  Psychopathology and psychological adjustment in children and adolescents with epilepsy.

Authors:  Soraya Otero
Journal:  World J Pediatr       Date:  2009-01-27       Impact factor: 2.764

10.  Social anxiety and self-concept in children with epilepsy: a pilot intervention study.

Authors:  Jana E Jones; Jacquelyn B Blocher; Daren C Jackson; Connie Sung; Mayu Fujikawa
Journal:  Seizure       Date:  2014-07-08       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.